CA9 and hereditary clear cell renal cell carcinoma: Furthermore, carbonic anhydrase IX (CAIX)-targeted CAR-T cell therapy in renal cell carcinoma trials resulted in liver enzyme abnormalities due to CAR-T cell infiltration in the bile duct epithelium expressing CAIX.